-+ 0.00%
-+ 0.00%
-+ 0.00%

Preview: Protalix BioTherapeutics's Earnings

Benzinga·11/12/2025 17:02:12
Listen to the news

Protalix BioTherapeutics (AMEX:PLX) will release its quarterly earnings report on Thursday, 2025-11-13. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Protalix BioTherapeutics to report an earnings per share (EPS) of $0.05.

Investors in Protalix BioTherapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Performance in Previous Earnings

During the last quarter, the company reported an EPS missed by $0.03, leading to a 2.63% drop in the share price on the subsequent day.

Here's a look at Protalix BioTherapeutics's past performance and the resulting price change:

Quarter Q2 2025 Q1 2025 Q4 2024 Q3 2024
EPS Estimate 0.03 0.08 0.07 0.06
EPS Actual 0.00 -0.05 0.09 0.03
Price Change % -3.00 -40.00 -4.00 -1.00

eps graph

Stock Performance

Shares of Protalix BioTherapeutics were trading at $2.13 as of November 11. Over the last 52-week period, shares are up 50.0%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Protalix BioTherapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.